Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 3, 2007, Pages 183-186

  Pound, Catherine M ^a   Keene, Daniel L ^a   Udjus, Kristin ^a   Humphreys, Peter ^a   Johnston, Donna L ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Acute lymphoblastic leukemia; Cerebral vasospasm; Cytarabine; Encephalopathy

Indexed keywords

ASPARAGINASE MACROGOL; CYTARABINE; DEXAMETHASONE; VINCRISTINE;

ACUTE BRAIN DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; APHASIA; ARTICLE; BEHAVIOR CHANGE; BRAIN VASOSPASM; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; HUMAN; INCONTINENCE; LYMPHATIC LEUKEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; VISUAL HALLUCINATION; WEAKNESS;

ACUTE DISEASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BRAIN; BRAIN DISEASES; CHILD; CYTARABINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SPINAL; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MAGNETIC RESONANCE ANGIOGRAPHY; POLYETHYLENE GLYCOLS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 34247566177     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3180335043     Document Type: Article

References (12)

1. Vaughn DJ, Jarvik JG, Hackney D, et al. High-dose cytarabine neurotoxicity: MR findings during the acute phase. Am J Neuroradiol. 1993;14:1014-1016.
2. Hollinger P, Zenhausern R, Schroth G, et al. MR findings in Balint's syndrome, following intrathecal methotrexate and cytarabine in adult acute lymphoblastic leukemia. Eur Neurol. 2001;46:166-167.
3. Winick N, Shuster JJ, Bowman WP, et al. Intensive oral MTX protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia. J Clin Oncol. 1996;14:2803-2811.
4. Leonard JV, Kay JD. Acute encephalopathy and hyperammonaemia complicating treatment of acute lymphoblastic leukaemia with asparaginase. Lancet. 1986;1:162-163.
5. Kingma A, Tamminga RY, Kamps WA, et al. Cerebrovascular complications of L-asparaginase therapy in children with leukemia: aphasia and other neuropsychological deficits. Pediatr Hematol Oncol. 1993;10:303-309.
6. Priest JR, Ramsay NK, Latchaw RE, et al. Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer. 1980;46:1548-1554.
7. Priest JR, Ramsay NK, Bennett AJ, et al. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr. 1982;100:990-995.
8. Jalan R, Olde Damink SW, Hayes PC, et al. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol. 2004;41:613-620.
9. Vera P, Rohrlich P, Stievenrat JL, et al. Contribution of single-photon emission computed tomography in the diagnosis and follow-up of CNS toxicity of a cytarabine-containing regimen in pediatric leukemia. J Clin Oncol. 1999;17:2804-2810.
10. Baker WJ, Royer GL, Weiss RB. Cytarabine and neurologic toxicity. J Clin Oncol. 1991;9:679-693.
11. Schaefer PW, Copen WA, Lev MH et al. Diffusion-weighted imaging in acute stroke. Diffusion-weighted imaging in acute stroke. Neuroimaging Clin N Am. 2005;15:503-530.
12. Henderson RD, Rajah T, Nicol AJ, et al. Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology. 2003;60:326-328.